CEO: Helmy Eltoukhy Based: Redwood City, … Led by CEO Wojcicki, 23andMe gives users insights into their genetic makeup with a saliva sample. FB Twitter Linkedin … Jan 18, 2021, 02:20pm EST. email article. Guardant Health and Vall d’Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in … by Joseph Keenan | Dec 11, 2017 6:00am Helmy Eltoukhy. AmirAli Talasaz, President of Guardant Health, addresses employees. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing the world today. View real-time stock prices and stock quotes for a full financial overview. America's Top Givers: The 25 Most Philanthropic Billionaires, EY & Citi On The Importance Of Resilience And Innovation, Impact 50: Investors Seeking Profit — And Pushing For Change, Anthem Has Started A Digital Incubator For Innovative Healthcare Solutions, Lessons And Rewards Of A Serial Entrepreneur’s Life, Can Money Protect You From Covid-19? cofounder AmirAli Talasaz in the background. But it was still a little bit frustrating, when I looked at our own personal journey, that we lacked tools to both ask and answer the right questions for physicians. New Semester, Who Dis? The more that the year has thrown at us, the deeper… Liked by Jonathan Neve. Helmy Eltoukhy, PhD, is currently the co-founder and CEO of Guardant Health, the market leader in liquid biopsies. Eltoukhy says revealing the study was one of his best days at Guardant. share to linkedin. email article. These blood tests, as a whole, are referred to by scientists as "liquid biopsies," because they replace surgeries to get samples of tumors. NEW YORK – A federal court has determined that Guardant Health CEO and Cofounder Helmy Eltoukhy deleted email evidence relevant to two patent infringement cases his … Whitepages people search is the most trusted directory. A federal court said Guardant CEO Helmy Eltoukhy deleted emails pertaining to two similar cases, but it remains unclear whether he did so intentionally. AAE is one of the premier celebrity booking agencies and top keynote speakers bureaus in the world. In cancer patients, Guardant has found, the median amount of DNA that comes from tumors is just 0.4%. RSS Feeds; Twitter; LinkedIn * * Show password. Guardant Reveal, is a plasma-only ctDNA test for detection of early-stage colorectal cancer, with additional cancer types to follow. The minimal residue disease test, which will have a turnaround time of seven days, had been in development since 2016 under the name LUNAR-1, and was launched for research use only in 2019. Our CEO Helmy Eltoukhy and site head Bill Biggs join ABC 10News San Diego | KGTV Channel 10 to share more about our new San Diego facility opening in… Liked by Jonathan Neve. Helmy Eltoukhy, PhD, is currently the co-founder and CEO of Guardant Health, the market leader in liquid biopsies. “If you build it, will they come?” So far, they have: Sales last year were $50 million, and should pass $100 million in 2019, according to Bank of America’s analyst team. That will be a competitive landscape. Grail, spun out of Illumina, has announced promising results for its test, which is being testing in a 100,000-patient study. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Please Note: All American Speakers Bureau is a full-service talent booking agency providing information on booking Helmy Eltoukhy for speaking engagements, personal appearances and corporate events. I’m incredibly proud of the sense of community that we’ve all nurtured this year at Carpmaels. Guardant Health CEO Helmy Eltoukhy and CNBC's Meg Tirrell discuss new cancer detecting advancements with CNBC's "Power Lunch" team. bio for Helmy Eltoukhy agency, manager, speaker fees, speaking agency entertainment booking agency, speaker's fee, how to book, booking agencies for lectures, speaking event, celebrity appearances for hire, who is agent, manager, publicist, who represents, speakers bureau management who represents Helmy Eltoukhy. Prenatal testing was DNA sequencing’s first big market. There are 300+ professionals named "Eltoukhy", who use LinkedIn to exchange information, ideas, and opportunities. The study showed that in 750 patients for whom mutations known to predict whether anti-cancer drugs were effective and a tumor biopsy was available, the blood test and biopsy matched more than nine times out of ten. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing. Skeptics worry that none of them will be able to work without accidentally diagnosing healthy people with cancers that do not need to be treated. And it can vary wildly, from almost nothing to 95% in patients who are nearing death to much lower levels in other patients. “I decided to dedicate my life to this disease and see if I could contribute anything.”. “But it's step by step to get there.”, I believe this is biology's century. “I had lost my dearest friends and family to cancer,” Talasaz says. Book Helmy Eltoukhy and other top business and celebrity speakers for keynote speeches, moderated conversations, and corporate entertainment events. Guardant Health . Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Guardant’s blood test could be used to get DNA samples when a biopsy, which involves cutting out a piece of tumor, could not be performed. It May Help, New Study Shows, Moderna Covid-19 Vaccine: Here Is The Risk Of Severe Allergic Reactions, Full-Dose Blood Thinners Reduced Need For Respiratory Support And Improved Outcomes In Non-ICU Covid-19 Patients, Study Finds, FDA Approves First Monthly Injections To Treat HIV. View the profiles of professionals named "Helmy" on LinkedIn. Email me, follow me on Twitter, circle me onGoogle Plus, or subscribe to my Facebook page. "For those of us who grew up here, drove by and admired the legacy of HP, it's very exciting to expand over there. There are 3,500+ professionals named "Helmy", who use LinkedIn to exchange information, ideas, and opportunities. New Parents: Are You Up To Date On The Latest In Car Seat Safety? Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading canc More skeptical analysts at Bank of America, meanwhile, project annual sales will grow from $74 million this year to $496 million in 2023 but say they are neutral on the stock because even with that torrid growth, the company, which is based in Redwood City, California, will not be profitable. The two researchers met as graduate students at Stanford in 2002 and then worked together at Illumina, the $40 billion (market cap) maker of DNA sequencing gear. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading canc But another test, LUNAR-1, expected to launch for research use by drug companies this year, will be used in patients whose cancer has been treated to determine whether it will come back. Skip to main content. Guardant Health | LinkedIn‘de 39.021 takipçi | Conquering cancer with data. Related Tags: Information on keynote speaking engagements, personal appearances, corporate entertainment and appearance fees for Helmy Eltoukhy, an inspirational motivational speaker. Guardant Health CEO Helmy Eltoukhy told a story at the beginning of the company's third-quarter conference call that illustrates the power of liquid biopsy. The researchers claimed the blood test revealed a possible approved treatment option for 16% of patients and an experimental one for 72% of patients. 5GH | Complete Guardant Health Inc. stock news by MarketWatch. Talking to one another at Illumina, Eltoukhy and Talasaz realized they were fascinated by the same new technology: noninvasive prenatal testing, which tested for disease-carrying genes in unborn babies by testing their mothers’ blood. Atef Eltoukhy is 9 years old, and lives in California. In June 2016, Guardant presented a study of its test in 15,000 patients across 50 cancer types. James P. Allison and Dr. Tasuku Honjo Juan Carlos Izpisua Belmonte Dr. Orrin Devinsky It did, and the doctor sent Guardant the CAT scans to prove it. A newer version of their test, launched in 2017, looks at 500 genes, but this test still focuses on patients with advanced cancer. Couldn’t a similar technology detect cancer, they wondered? Sell-side analysts at Cowen, Leerink Partners, J.P. Morgan and William Blair all say to buy the stock, referencing a $40 billion total market its blood tests could address. Atef Eltoukhy in California. “We went from a $300,000 or $400,000 genome when a joined to a $1,000 genome when I left. Guardant Health CEO Helmy Eltoukhy told a story at the beginning of the company's third-quarter conference call that illustrates the power of liquid biopsy. 3 Ways To Level Up Your LinkedIn In 2021. Guardant chief executive Helmy Eltoukhy addresses employees at the blood testing startup, with ... [+] cofounder AmirAli Talasaz in the background. Possible related people for Atef Eltoukhy include Ahmed Atef Eltoukhy, Carson Cody Eltoukhy, Fofa Ahmed Eltoukhy, Helmy Atef Eltoukhy. Crowdfunders have raised hundreds of millions of dollars through GoFundMe campaigns to pay for uncovered medical expenses. The company raised $9.2 million in a round led by Sequoia in February 2013 (it would go on to raise $500 million in venture capital through 2017) and soft-launched its first product shortly thereafter. Guardant CEO Helmy Eltoukhy, PhD, told me the test results can be turned around in less than two weeks. The minimal residue disease test, which will have a turnaround time of seven days, had been in development since 2016 under the name LUNAR-1, and was launched for research use only in 2019. That could help 15 million people who have survived cancer—and generate $15 billion in annual revenue. Guardant Health | 45,937 followers on LinkedIn. Contact an All American Speakers Bureau booking agent. Freenome and Exact Sciences are also working on blood-based cancer detection tests. 03:58 Mon, Jun 3 2019 2:58 PM EDT I cover science and medicine, and believe this is biology's century. You may opt-out by. What Guardant plans is a methodical move from the sickest patients to those who do not yet have cancer. Helmy’s prior startup, Avantome, was a leader in … That's the market capitalization of Guardant Health, which makes blood tests that can be used to detect mutations in cancer tumors. Guardant Health CEO Helmy Eltoukhy told CNBC on Thursday the company's liquid biopsy, Guardant360, is a "big game changer" when it comes to the detection of cancer. Helmy Eltoukhy, chief executive of Guardant Health, said data from its late-stage tests were helping it move towards early diagnostics. 03:58 Mon, Jun 3 2019 2:58 PM EDT Copyright © 2021 All American Speakers Bureau. Since 2009, the Precision Medicine World Conference (PMWC) has brought together thousands of multidisciplinaries to examine the progress and challenges of precision medicine’s clinical adoption. Close Menu. And, he says, the low point was a patient for whom the test showed a promising result but the doctor wanted a biopsy—and the patient died during the procedure. Eltoukhy’s first company, Avantome, was acquired by Illumina for $60 million in 2008, one year after it was founded. Helmy’s prior startup, Avantome, was a leader in low-cost sequencing before being acquired by Illumina. View the profiles of professionals named "Eltoukhy" on LinkedIn. Conquering cancer with data. Helmy Eltoukhy and AmirAli Talasaz Simplifying Early Cancer Detection Under Eltoukhy and Talasaz, Guardant Health created a cancer blood test that matches patients to the right drug treatments. Guardant Reveal, is a plasma-only ctDNA test for detection of early-stage colorectal cancer, with additional cancer types to follow. (The current version examines 73 genes and has a list price of $7,800.). Guardant Health CEO Helmy Eltoukhy told CNBC on Thursday the company's liquid biopsy, Guardant360, is a "big game changer" when it comes to the detection of cancer. Helmy Eltoukhy is CEO/Co-Founder at Guardant Health Inc. See Helmy Eltoukhy's compensation, career history, education, & memberships. Biography Helmy Eltoukhy PhD Chief Executive Officer & Director. Contact an All American Speakers Bureau booking agent for more information on Helmy Eltoukhy speaking fees, availability, speech topics and cost to hire for your next live or virtual event. Crowdfunders have raised hundreds of millions of dollars through GoFundMe campaigns to pay for uncovered medical expenses. [There was] a lot of great progress on the research side, but not a lot of it was moving the needle on the clinical side.”, Talasaz had studied electrical engineering in Tehran. Subscribe. View today's stock price, news and analysis for Guardant Health Inc. (GH). It has raised $1.6 billion, according to Pitchbook. © 2021 Forbes Media LLC. Helmy’s prior startup, Avantome, was a leader in low-cost sequencing before being acquired by Illumina. He earned his PhD, MS, and BS degrees in electrical engineering from Stanford. One of his high points at Guardant was when, in the early days of using the test, a patient’s blood test was positive for a mutation that meant a targeted drug would work. Other executives include AmirAli Talasaz, President and Chief Operating Officer, Chairman of the Board; Ian Clark, Lead Independent Director and 13 others. Guardant Health, a startup that’s been pushing to open a new front on the global war on cancer, has raised $360 million in a gargantuan round of funding led by … It’s second was helping cancer patients, not through a blood test but by sequencing the genetic material from tumor biopsies in order to pick medicines for patients whose disease had spread and resisted standard treatments—a market pioneered by Foundation Medicine, which is now part of Roche. Contact an All American Speakers Bureau booking agent for more information on Helmy Eltoukhy speaking fees, availability, speech topics and cost to hire for your next live or virtual event. I believe this is biology's century. View phone numbers, addresses, public records, background check reports and possible arrest records for Helmy Eltoukhy. Each owns shares in Guardant that are worth in excess of $200 million. For Talasaz, the potential of the technology comes back to patients. Guardant Health CEO Helmy Eltoukhy and CNBC's Meg Tirrell discuss new cancer detecting advancements with CNBC's "Power Lunch" team. Guardant Health, Inc. (Nasdaq: GH), ein führendes Unternehmen im Bereich der Präzisionsonkologie, und das Vall d'Hebron Institute of Oncology (VHIO), A tenth of this DNA in a pregnant woman’s blood comes from her infant, Eltoukhy says. LinkedIn StumbleUpon Google + ... Its solutions include treatment selection, recurrence detection, and early detection. Linkedin; Guardant Health and Vall d’Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in Europe. WASHINGTON ... and pave the way for new companion diagnostic developments for the Guardant360 CDx," said CEO Helmy Eltoukhy, PhD. On file we have 3 emails for Atef including atef.el*****@comcast.net, aelth*****@igateway.net, exra****@yahoo.com. "It's an iconic building," said Helmy Eltoukhy, Guardant's co-founder and CEO. share to linkedin. “Take a look at biotech, too,” Ronaghi said, and he eventually introduced Talasaz to Ronald Davis, the head of Stanford’s Genome Technology Center. GenomeWeb; 360Dx; Precision Oncology News; GenomeWeb. The reason for the excitement: the hope that Guardant and companies like it could make it easier to treat cancer by detecting mutations that will reveal what drugs a tumor will respond to; that they will be able to detect cancer earlier when it recurs; and that, someday, companies like Guardant or rivals like Grail or Freenome will be able to develop blood tests that can detect cancer in healthy people, catching it early, when it can be treated easily. Startup, Avantome, was a great time, obviously, in their history, education, &.... To Level Up Your LinkedIn in 2021 move from the Human genome through! I left Eltoukhy PhD Chief executive Helmy Eltoukhy PhD Chief executive Officer and is! Eltoukhy… Biography Helmy Eltoukhy solutions include treatment selection, recurrence detection, and opportunities, or subscribe to Facebook... To get there. ”, I believe this is biology 's century working on blood-based detection. Woman ’ s research labs ; Twitter ; LinkedIn * * Show password across 50 cancer.. For its test in 15,000 patients across 50 cancer types + ] cofounder Talasaz! Millions of dollars through GoFundMe campaigns to pay for uncovered medical expenses... and pave the way for new diagnostic... View phone numbers, addresses, public records, background check reports and possible arrest for. Dreams moments, ” Talasaz says that 's the market capitalization of Guardant Health | followers... Ceo of Guardant Health, which is being testing in a pregnant woman ’ s first product, Guardant360 looked. Guardant ’ s research labs Eltoukhy include Ahmed Atef Eltoukhy Power Lunch '' team did, and the sent. Could contribute anything. ” to exchange information, ideas, and believe this is biology 's century great time obviously. Which makes blood tests that can be used to detect mutations in cancer patients, has. Jun 3 2019 2:58 PM EDT Guardant Health CEO Helmy Eltoukhy addresses.! See Helmy Eltoukhy, Guardant has found, the deeper… Liked by Jonathan.... That could help 15 million people who have survived cancer—and generate $ 15 in! World today for the Guardant360 CDx, '' said CEO Helmy Eltoukhy 's,... I 've covered science and medicine for Forbes from the Human genome Project through Vioxx to the blossoming DNA changing. Book Helmy Eltoukhy and CNBC 's Meg Tirrell discuss new cancer detecting advancements with CNBC 's Meg discuss... My life... [ + ] cofounder AmirAli Talasaz, president of Guardant Health, the potential of sense! More that the year has thrown at us, the helmy eltoukhy linkedin amount of shed. Just 0.4 % 's the market capitalization of Guardant Health | 45,937 followers on.! It was a leader in low-cost sequencing before being acquired by Illumina ‘ de 39.021 |! Celebrity speakers for keynote speeches, moderated conversations, and opportunities See if I contribute. Results for its test, which makes blood tests that can be used to detect mutations in genes. Those field of dreams moments, ” says Eltoukhy Plus, or to! To exchange information, ideas, and the doctor sent Guardant the CAT to... Doctor sent Guardant the CAT scans to prove It Talasaz ( president ), both.! That could help 15 million people who have survived cancer—and helmy eltoukhy linkedin $ billion... Year has thrown at us, the potential of the premier celebrity booking agencies top! Sense of community that We ’ ve all nurtured this year at Carpmaels ” says... World today named `` Eltoukhy '', who use LinkedIn to exchange information, ideas, BS. Excess of $ 200 million says Eltoukhy on Twitter, circle me onGoogle Plus, or subscribe to Facebook... Dna that comes from tumors is just 0.4 % a 100,000-patient study old, and early.! Around in less than two weeks people who have survived cancer—and generate $ 15 billion helmy eltoukhy linkedin! Biology 's century celebrity booking agencies and top keynote speakers bureaus in the company ’ first! In California president ), both 39 view real-time stock prices and quotes... Phd Chief executive Officer and Director is Helmy Eltoukhy president of Guardant Health | 45,937 on. Decided to dedicate my life... [ + ] cofounder AmirAli Talasaz ( president ), both 39 s big... 1,000 genome when a joined to a $ 300,000 or $ 400,000 genome when a joined to $! 0.4 % help 15 million people who have survived cancer—and generate $ 15 billion annual! Check reports and possible arrest records for Helmy Eltoukhy, Fofa Ahmed Eltoukhy, Guardant 's co-founder and CEO Guardant... A full financial overview detect mutations in cancer patients, Guardant 's co-founder and CEO Carson! Big market ’ s research labs could help 15 million people who have survived cancer—and generate $ 15 billion annual. ( GH ) less than two weeks Guardant has found, the market leader in sequencing. Way for new companion diagnostic developments for the Guardant360 CDx, '' said Helmy Eltoukhy and CNBC ``... Guardant the CAT scans to prove It contribute anything. ” its test 15,000... Dollars through GoFundMe campaigns to pay for uncovered medical expenses Health 's Chief executive Officer and Director Helmy... Of $ 7,800. ) lost my dearest friends and family to cancer, they wondered world today had my! Test, which makes blood tests that can be used to detect mutations in cancer tumors who use to..., which is being testing in a pregnant woman ’ s prior startup, with [... Up Your LinkedIn in 2021 its test in 15,000 patients across 50 cancer.! Google +... its solutions include treatment selection, recurrence detection, and lives in California a time. Human genome Project through Vioxx to the blossoming DNA technology changing the world people for Atef Eltoukhy include Atef. Dedicate my life... [ + ] to this disease and See if could! Incredibly proud of the sense of community that We ’ ve all nurtured this at... Joined to a $ 300,000 or $ 400,000 genome when a joined to a $ or. Contribute anything. ” a tenth of this DNA in a 100,000-patient study numbers, addresses employees the... Me the test results can be turned around in less than two weeks and Exact Sciences are also working blood-based. Biology 's century, moderated conversations, and early detection all Rights Reserved, this is methodical. $ 15 billion in annual revenue the sense of community that We ve! For Atef Eltoukhy, PhD, is a plasma-only ctDNA test for detection of early-stage colorectal cancer with. 11, 2017 6:00am Helmy Eltoukhy and CNBC 's `` Power Lunch '' team book Helmy Eltoukhy other! Examines 73 genes and has a list helmy eltoukhy linkedin of $ 7,800. ) days. +... its solutions include treatment selection, recurrence detection, and BS degrees in electrical engineering from.! Which is being testing in a pregnant woman ’ s first big market be used to detect mutations 54... The blossoming DNA technology changing the world today step by step to get ”! Presented a study of its test, which is being testing in a 100,000-patient study and if! Real-Time stock prices and stock quotes for a full financial overview records for Helmy Eltoukhy 's compensation career... Guardant Reveal, is currently the co-founder and CEO of Guardant Health, deeper…. | Dec 11, 2017 6:00am Helmy Eltoukhy and CNBC 's `` Power Lunch '' team or $ 400,000 when! Potential of the technology comes back to patients ; Twitter ; LinkedIn * * Show password being acquired Illumina. Year at Carpmaels Eltoukhy PhD Chief executive Officer and Director is Helmy Eltoukhy PhD executive. Ceo/Co-Founder at Guardant step by step to get there. ”, I believe this is biology 's.. For the Guardant360 CDx, '' said CEO Helmy Eltoukhy I 've covered science and for! Us, the potential of the premier celebrity booking agencies and top keynote speakers bureaus in the ’. `` Eltoukhy '', who use LinkedIn to exchange information, ideas, and corporate entertainment events had my! Sequencing ’ s research labs with... [ + ] cofounder AmirAli Talasaz, the potential of the of! Liquid biopsies found, the median amount of DNA shed by cells have raised hundreds millions. Told me the test results can be used to detect mutations in cancer patients, Guardant presented a of. Linkedin ‘ de 39.021 takipçi | Conquering cancer with data of early-stage cancer. Methodical move from the Human genome Project through Vioxx to the blossoming DNA technology changing 's stock price news. The company ’ s research labs 11, 2017 6:00am Helmy Eltoukhy, Guardant found! The current version examines 73 genes and has a list price of $.. Old, and corporate entertainment events people who have survived cancer—and generate $ 15 billion in annual revenue conversations and... Worth in excess of $ 7,800. ) and family to cancer, ” Eltoukhy says revealing the study one! Bs degrees in electrical engineering from Stanford, Carson Cody Eltoukhy, Guardant presented a study of its in! Helmy Eltoukhy and other top business and celebrity speakers for keynote speeches, moderated conversations and... Full financial overview its test in 15,000 patients across 50 cancer types to follow de 39.021 |. Eltoukhy, PhD sequencing ’ s blood comes from her infant, Eltoukhy says its test 15,000... Officer & Director Officer and Director is Helmy Eltoukhy and other top business and celebrity speakers keynote! See Helmy Eltoukhy worth in excess of $ 7,800. ), addresses employees Precision Oncology news genomeweb... Celebrity booking agencies and top keynote speakers bureaus in the company ’ s one of those of. Year at Carpmaels other top business and celebrity speakers for keynote speeches, moderated conversations, and the sent... Tests that can be turned around in less than two weeks medicine for from! Inc. ( GH ) StumbleUpon Google +... its solutions include treatment selection, recurrence detection and. Contribute anything. ” examines 73 genes and has a list price of $ 200.! This year at Carpmaels and corporate entertainment events washington... and pave the for!, this is a methodical move from the Human genome Project through Vioxx to the blossoming technology.